News | May 25, 2017

Harpoon Therapeutics Announces Completion Of $45M Series B Financing MPM Capital, Arix Bioscience, New Leaf Venture Partners and Taiho Ventures Participate in Immuno-Oncology Financing South San Francisco, CA—May 25, 2017-Harpoon Therapeutics, a biotechnology company...

News | May 23, 2017

Bioverativ to Acquire Clinical-Stage Rare Disease Biotechnology Company, True North Therapeutics – Strengthens pipeline with lead candidate TNT009 in cold agglutinin disease, a rare and chronic autoimmune hemolytic anemia with no approved therapies –...

News | May 22, 2017

Versartis Presents 3-Year Somavaratan Safety and Efficacy Data and Pediatric Program Baseline Demographics at the 19th European Congress of Endocrinology MENLO PARK, Calif., May 22, 2017 (GLOBE NEWSWIRE) — Versartis, Inc. (NASDAQ:VSAR), an endocrine-focused...

News | May 19, 2017

Iterum Secures $65 Million in Series B Financing Funding to support the Phase 3 clinical development of oral penem antibiotic DUBLIN, IRELAND, and CHICAGO –May 19, 2017 – Iterum Therapeutics Limited, an Irish clinical-stage pharmaceutical company focused on the...

News | April 28, 2017

Truveris selected by New Jersey to implement reverse auction and price transparency platform for pharmaceutical benefits Apr 28, 2017 Truveris will use our innovative, proprietary technology to measure the value of New Jersey’s public employee benefits contracts. The...
libero. vel, id facilisis fringilla Curabitur